A study to assess the effect AZD4831 in Japanese and Chinese healthy volunteers

Trial Identifier: D6580C00008
Sponsor: AstraZeneca
Collaborator:
Parexel International
NCTID:: NCT04232345
Start Date: January 2020
Primary Completion Date: March 2021
Study Completion Date: March 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Japanese (US) Translation
Simplified Chinese (US) Translation

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206